Management of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (NVAF) who are older and frail, with moderate renal impairment and multiple comorbidities.

30 August 2021 (10:00 - 11:00)
Organised by:

ESC 365 is supported by

ESC 365 is supported by